Displaying drugs 51 - 75 of 136 in total
| DrugBank ID | Name CAS Number |
Weight Formula |
Structure | Categories | Therapeutic Indication |
|---|---|---|---|---|---|
| DB00007 |
Leuprolide
53714-56-0 |
1209.3983 C59H84N16O12 |
|
Antineoplastic Agents / Anti-Estrogen Agents | For treatment of prostate cancer, endometriosis, uterine fibroids and premature puberty |
| DB00001 |
Lepirudin
120993-53-5 |
6963.4250 C287H440N80O110S6 |
|
Anticoagulants / Antithrombotic Agents / Fibrinolytic Agents | For the treatment of heparin-induced thrombocytopenia |
| DB00090 |
Laronidase
210589-09-6 |
69899.4000 C3160H4848N898O881S12 |
|
Enzyme Replacement Agents | For the treatment of mucopolysaccharidosis |
| DB00028 |
Intravenous Immunoglobulin
9007-83-4 |
142682.3000 C6332H9826N1692O1980S42 |
|
Immunomodulatory Agents / Anti-Infectives | IVIg is used in the treatment of immunodeficiencies, as well as autoimmune and inflammatory disorders. These indications includes idiopathic thromb... |
| DB00033 |
Interferon gamma-1b
82115-62-6 |
17145.6000 C761H1206N214O225S6 |
|
Immunomodulatory Agents / Antiviral Agents | Interferon gamma-1b is used for the treatment of Chronic granulomatous disease and Osteopetrosis. |
| DB00068 |
Interferon beta-1b
145155-23-3 |
20011.0000 C908H1408N246O253S6 |
|
Immunomodulatory Agents / Antiviral Agents | Interferon beta-1b is a drug used for the treatment of relapsing/remitting multiple sclerosis. It has been shown to slow the advance of the disease... |
| DB00060 |
Interferon beta-1a
145258-61-3 |
20027.0000 C908H1408N246O252S7 |
|
Immunomodulatory Agents / Antiviral Agents | For treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatum |
| DB00069 |
Interferon alfacon-1
118390-30-0 |
19343.0000 C860H1353N227O255S9 |
|
Antineoplastic Agents / Immunomodulatory Agents / Antiviral Agents | For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma |
| DB00018 | Interferon alfa-n3 |
|
Antineoplastic Agents / Immunomodulatory Agents / Antiviral Agents | For the intralesional treatment of refractory or recurring external condylomata acuminata. | |
| DB00011 |
Interferon alfa-n1
74899-72-2 |
19241.1000 C860H1353N227O255S9 |
|
Immunomodulatory Agents / Antiviral Agents | For treatment of venereal or genital warts caused by the Human Papiloma Virus |
| DB00105 |
Interferon Alfa-2b, Recombinant
99210-65-8 |
19271.0000 C860H1353N229O255S9 |
|
Antineoplastic Agents / Immunomodulatory Agents / Antiviral Agents | For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma. |
| DB00034 |
Interferon Alfa-2a, Recombinant
77907-69-8 |
19241.1000 C860H1353N227O255S9 |
|
Antineoplastic Agents / Antiviral Agents | For the treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic myelogenous leukemia. Also for the treatm... |
| DB00071 |
Insulin, porcine
9004-14-2 |
5795.6000 C257H387N65O76S6 |
|
Hypoglycemic Agents | For the treatment of type I and II diabetes mellitus. |
| DB00030 |
Insulin recombinant
9004-10-8 |
5795.6000 C257H387N65O76S6 |
|
Hypoglycemic Agents | For treatment of Type I and II diabetes mellitus. |
| DB00046 |
Insulin Lispro
133107-64-9 |
5808.0000 C257H387N65O76S6 |
|
Hypoglycemic Agents / Antidiabetic | For the treatment of Type 1 or 2 diabetes mellitus. To be used in conjunction with an intermediate or long-acting insulin except when used in a con... |
| DB01309 |
Insulin Glulisine
207748-29-6 |
C258H384N64O78S6 |
|
Hypoglycemic Agents / Antidiabetic | For the treatment of Type 1 and 2 diabetes mellitus. Should be used in regimens including a long-acting or basal insulin analogue unless it is used... |
| DB00047 |
Insulin Glargine
160337-95-1 |
6063.0000 C267H408N72O77S6 |
|
Hypoglycemic Agents / Antidiabetic | For the treatment of Type 1 or 2 diabetes mellitus in patients over 17 years old who require a long-acting (basal) insulin for the control of hyper... |
| DB01307 |
Insulin Detemir
169148-63-4 |
C267H402N64O76S6 |
|
Hypoglycemic Agents / Antidiabetic | For the treatment of type 1 or 2 diabetes mellitus. May be used in combination with oral anti-diabetic agents in type 2 diabetic patients who are n... |
| DB01306 |
Insulin Aspart
116094-23-6 |
C256H381N65O79S6 |
|
Hypoglycemic Agents / Antidiabetic | For the treatment of Type 1 or 2 diabetes mellitus. Should normally be used in conjunction with an intermediate or long-acting insulin. |
| DB00065 |
Infliximab
170277-31-3 |
144190.3000 C6428H9912N1694O1987S46 |
|
Immunomodulatory Agents / Immunosuppressive Agents | To manage the signs and symptoms, as well as to induce and maintain clinical remission in adults with moderate to severe active Crohn's disease or ... |
| DB00053 |
Imiglucerase
143003-46-7 |
55597.4000 C2532H3854N672O711S16 |
|
Enzyme Replacement Agents | For the treatment of Gaucher's disease (deficiency in glucocerebrosidase) |
| DB01271 |
Idursulfase
50936-59-9 |
76000.0000 C2654H4000N688O774S14 |
|
Enzyme Replacement Agents | For the treatment of Hunter syndrome in adults and children ages 5 and older. |
| DB00078 |
Ibritumomab
174722-31-7 |
143375.5000 C6382H9830N1672O1979S54 |
|
Antineoplastic Agents | For treatment of non-Hodgkin's lymphoma |
| DB00070 |
Hyaluronidase
488712-31-8 |
53870.9000 C2455H3775N617O704S21 |
|
Anesthetic Adjuvants / Permeabilizing Agents | For increase of absorption and distribution of other injected drugs and for rehydration. |
| DB00062 |
Human Serum Albumin
9048-49-1 |
66472.2000 C2936H4624N786O889S41 |
|
Serum substitutes | For treatment of severe blood loss, hypervolemia, hypoproteinemia |
Displaying drugs 51 - 75 of 136 in total